Aspaveli® (pegcetacoplan) receives positive CHMP opinion for treatment of PNH
- Friday, October 15, 2021, 7:00
- Finance
- Add a comment
STOCKHOLM, Oct. 15, 2021 /PRNewswire/ — Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) and Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announce today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion…
About the Author
adminasapcorp has written 41718 stories on this site.